Narcolepsy Type 1

29 registered clinical trials studyying Narcolepsy Type 1 — 13 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Decreasing Nightmares in Adults With Narcolepsy NCT06383806	University of Utah	N/A
Not Yet Recruiting	A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1 NCT07455383	Alkermes, Inc.	Phase 3
Recruiting	Pain Assessment in Patients With Idiopathic REM Sleep Behaviour Disorder NCT07365566	University Hospital, Toulouse	N/A
Recruiting	Epidemiology of Narcolepsy Type 1 and Type 2 in Spain NCT07299097	Takeda	—
Recruiting	A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia NCT07096674	Centessa Pharmaceuticals (UK) Limited	Phase 2
Recruiting	Bacterial Translocation and Gut Microbiota in Type 1 Narcolepsy Patients Versus a Control Population NCT06292598	Centre Hospitalier Universitaire de Nīmes	—
Recruiting	A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia NCT06767683	Alkermes, Inc.	Phase 2 / Phase 3
Recruiting	A Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia NCT06752668	Centessa Pharmaceuticals (UK) Limited	Phase 2
Recruiting	Mind-wandering and Predictive Processes in Narcolepsy: a Putative Mechanism Through Covert REM Intrusions NCT06457945	Hospices Civils de Lyon	N/A
Recruiting	Deciphering the Interactions Between Food Intake, Sleepiness, and Nighttime Sleep Quality in Patients With Typ NCT06484348	Hospices Civils de Lyon	N/A
Completed	A Study of TAK-861 in People With Narcolepsy Type 1 NCT06505031	Takeda	Phase 3
Not Yet Recruiting	A Eight-Week Study of NLS-2 (Mazindol Extended Release) in Participants With Narcolepsy Type 1 NCT05914194	NLS Pharmaceutics	Phase 3
Completed	A Study of TAK-861 for the Treatment of Narcolepsy Type 1 NCT06470828	Takeda	Phase 3
Completed	Efficacy of the Dreem 3S Ambulatory Sleep Monitoring Device for the Evaluation of Narcolepsy NCT06531876	Beacon Biosignals	—
Recruiting	Mentalizating in Adults Suffering from Narcolepsy Type 1. NCT06336057	University Hospital, Toulouse	—
Completed	Improving Social Relationships for Adolescents With Central Disorders of Hypersomnolence NCT06251063	Boston Children's Hospital	N/A
Completed	A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Narcolepsy Type 1 (ALKS 2680-20 NCT06358950	Alkermes, Inc.	Phase 2
Unknown	Contribution of 7 Tesla MRI of the Hypothalamus in the Diagnosis of Type 1 Narcolepsy NCT05967832	Assistance Publique Hopitaux De Marseille	N/A
Unknown	A Pilot Observational Study to Assess the Ability of Continuous 'Home' EEG to Accurately Diagnose Narcolepsy a NCT05983731	Guy's and St Thomas' NHS Foundation Trust	—
Recruiting	A Study of TAK-861 for the Treatment of Selected Central Hypersomnia Conditions NCT05816382	Takeda	Phase 2 / Phase 3
Completed	Narcolepsy Nightmare Study NCT05709873	Northwestern University	N/A
Completed	A Study of TAK-861 in Participants With Narcolepsy Type 1 NCT05687903	Takeda	Phase 2
Completed	Evaluation of the Effectiveness of a Physical Activity Program on the Severity of Narcolepsy NCT05460052	Hospices Civils de Lyon	—
Completed	Transcutaneous Auricular Vagus Nerve Stimulation in Patients With Narcolepsy Type 1 NCT06241911	Liu Yonghong	N/A
Completed	Group Psychotherapy in Narcolepsy Type 1 NCT05314556	Cantonal Hospital of St. Gallen	N/A
Completed	Wake and Sleep State Transitions on a Portable Electroencephalogram (EEG) Device in Narcolepsy Type 1 (NT1) an NCT04445129	Takeda	—
Completed	Clinical and Neurophysiological Characteristics of Narcolepsy NCT05375890	I.M. Sechenov First Moscow State Medical University	—
Suspended	'A Profile of Physical Performance Variables in an Out-patient Adult Population With Narcolepsy' NCT04419792	University of Dublin, Trinity College	—
Unknown	Meditation-Relaxation (MR Therapy) for Sleep Paralysis. NCT04483310	Azienda Usl di Bologna	N/A